BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4829668)

  • 1. The effect propranolol, alprenolol and practolol on the vibrinolytic and factor VIII responses to adrenaline and salbutamol in man.
    Gader AM; Da Costa J; Cash JD
    Thromb Res; 1974 Jan; 4(1):25-33. PubMed ID: 4829668
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
    Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of several beta-blockers on blood pressure in the rat.
    Yamamoto J; Sekiya A; Maekawa H
    Jpn J Pharmacol; 1975 Aug; 25(4):465-71. PubMed ID: 1562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
    Siblíková O; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(5-6):259-70. PubMed ID: 6126105
    [No Abstract]   [Full Text] [Related]  

  • 6. Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
    Day MD; Roach AG
    Br J Pharmacol; 1974 Jul; 51(3):325-33. PubMed ID: 4451747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
    Frisk-Holmberg M; Ostman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):598-605. PubMed ID: 15099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic mechanisms in the systemic plasminogen active response to adrenaline in man.
    Cash JD; Woodfield DG; Allan AG
    Br J Haematol; 1970 Apr; 18(4):487-94. PubMed ID: 4393371
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in fibrinolysis and blood coagulation.
    Cash JD; Woodfield DG
    Lancet; 1969 Jan; 1(7584):54. PubMed ID: 4178796
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of two different beta-adrenergic blocking agents on the increase in fibrinolytic activity and factor VIII activity during submaximum and maximum exercise.
    Korsan-Bengtsen K; Conradson TB
    Scand J Haematol; 1974; 13(5):377-84. PubMed ID: 4616332
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation.
    Ingram GI; Jones RV; Hershgold EJ; Denson KW; Perkins JR
    Br J Haematol; 1977 Jan; 35(1):81-100. PubMed ID: 869996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.
    Berend N; Marlin GE
    Br J Clin Pharmacol; 1978 Mar; 5(3):207-11. PubMed ID: 207295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of bronchial beta-adrenoceptor blockade in man.
    Gribbin HR; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1979 Jun; 7(6):551-6. PubMed ID: 37867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective action of beta-adrenoceptor blocking drugs and the nature of beta1 and beta2 adrenoceptors.
    Coleman AJ; Somerville AR
    Br J Pharmacol; 1977 Jan; 59(1):83-93. PubMed ID: 13902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the vasodilator action of alprenolol.
    Himori N; Izumi A; Ishimori T
    Eur J Pharmacol; 1978 Feb; 47(3):341-50. PubMed ID: 631185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone action at the membrane level. VI. Binding of (-)-[3H]dihydroalprenolol and (+/-)-[3H]isoproterenol to turkey erythrocytes and correlation with adenylate cyclase activity.
    Malchoff CD; Marinetti GV
    Biochim Biophys Acta; 1978 Feb; 538(3):541-54. PubMed ID: 203330
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of beta-receptor blocking agents propranolol and practolol on ST-T changes in neurocirculatory asthenia.
    Wolf E; Braun K; Stern S
    Br Heart J; 1974 Sep; 36(9):872-9. PubMed ID: 4425601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.